Abstract

Understanding the mechanisms that enable cancer cells to metastasize is essential in preventing cancer progression. Here we examine the metabolic adaptations of metastasis-initiating cells (MICs) in female breast cancer and how those shape their metastatic phenotype. We find that endogenous MICs depend on the oxidative tricarboxylic acid cycle and fatty acid usage. Sorting tumor cells based upon solely mitochondrial membrane potential or lipid storage is sufficient at identifying MICs. We further identify that mitochondrially-generated citrate is exported to the cytoplasm to yield acetyl-CoA, and this is crucial to maintaining heightened levels of H3K27ac in MICs. Blocking acetyl-CoA generating pathways or H3K27ac-specific epigenetic writers and readers reduces expression of epithelial-to-mesenchymal related genes, MIC frequency, and metastatic potential. Exogenous supplementation of a short chain carboxylic acid, acetate, increases MIC frequency and metastasis. In patient cohorts, we observe that higher expression of oxidative phosphorylation related genes is associated with reduced distant relapse-free survival. These data demonstrate that MICs specifically and precisely alter their metabolism to efficiently colonize distant organs.

Understanding the mechanisms associated with cancer metastasis may help control cancer progression. Here the authors investigate the metabolism of metastasis initiating cells in breast cancer and show that their metastatic ability relies on fatty acid oxidation and the oxidative tricarboxylic acid cycle, which in turn regulates acetyl-CoA generation and the acetylation of histones on EMT related genes.

Details

Title
Metabolic dependencies of metastasis-initiating cells in female breast cancer
Author
Young, C. Megan 1 ; Beziaud, Laurent 1 ; Dessen, Pierre 1 ; Madurga Alonso, Angela 1   VIAFID ORCID Logo  ; Santamaria-Martínez, Albert 2   VIAFID ORCID Logo  ; Huelsken, Joerg 1   VIAFID ORCID Logo 

 École Polytechnique Fédérale de Lausanne (EPFL), ISREC (Swiss Institute for Experimental Cancer Research), Lausanne, Switzerland (GRID:grid.5333.6) (ISNI:0000 0001 2183 9049); Agora Cancer Research Center, Lausanne, Switzerland (GRID:grid.5333.6); Swiss Cancer Center Léman, Lausanne, Switzerland (GRID:grid.511014.0) 
 École Polytechnique Fédérale de Lausanne (EPFL), ISREC (Swiss Institute for Experimental Cancer Research), Lausanne, Switzerland (GRID:grid.5333.6) (ISNI:0000 0001 2183 9049); Swiss Cancer Center Léman, Lausanne, Switzerland (GRID:grid.511014.0) 
Pages
7076
Publication year
2023
Publication date
2023
Publisher
Nature Publishing Group
e-ISSN
20411723
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2885956013
Copyright
© The Author(s) 2023. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.